Quantbot Technologies LP Purchases Shares of 2,026 Astera Labs, Inc. $ALAB

Quantbot Technologies LP acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 2,026 shares of the company’s stock, valued at approximately $979,000.

Several other institutional investors also recently modified their holdings of the company. Glenmede Trust Co. NA increased its position in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the last quarter. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs in the second quarter valued at $25,000. Lido Advisors LLC increased its holdings in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares during the last quarter. Goldstein Advisors LLC raised its position in shares of Astera Labs by 5.8% in the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares during the period. Finally, Johnson Financial Group Inc. bought a new position in shares of Astera Labs in the second quarter valued at about $43,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ALAB has been the subject of several research analyst reports. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price for the company in a report on Monday, August 17th. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Royal Bank Of Canada boosted their price objective on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. TD Cowen decreased their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Finally, Evercore reiterated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $333.00.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $290.30 on Thursday. The company has a market capitalization of $50.36 billion, a P/E ratio of 143.71 and a beta of 3.84. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The business’s 50 day simple moving average is $347.19 and its 200 day simple moving average is $248.42.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue was up 104.5% on a year-over-year basis. During the same quarter last year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the sale, the director directly owned 4,631 shares of the company’s stock, valued at $2,083,950. This represents a 66.01% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 419,244 shares of company stock valued at $163,135,169 in the last ninety days. Insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.